A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results


Danson, Sarah, Plummer, Ruth, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Hook, Jane, Marshall, Helen, Sagoo, Gurdeep, Meads, David, Bestall, Janine, Velikova, Galina, Gallagher, Ferdia et al (show 6 more authors) (2019) A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results. .

Access the full-text of this item by clicking on the Open Access link.
Item Type: Conference or Workshop Item (Unspecified)
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 23 Dec 2021 08:05
Last Modified: 18 Jan 2023 21:18
Open Access URL: https://pubmed.ncbi.nlm.nih.gov/34210290/
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3145887
CORE (COnnecting REpositories)